Biomarin Pharmaceutical Inc BMRN:NASDAQ

Last Price$76.50NASDAQ Closing Price as of 4:00PM ET 9/16/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.77(1.00%)
Bid (Size)$75.00 (8)
Ask (Size)$77.40 (4)
Day Low / High$75.82 - 77.30
Volume813.2 K
 

View Biotechnology IndustryPeer Comparison as of 09/16/2021

 

Biomarin Pharmaceutical Inc ( NASDAQ )

Price: $76.50
Change: -0.77 (1.00%)
Volume: 813.2 K
4:00PM ET 9/16/2021
 
 

Incyte Corp ( NASDAQ )

Price: $75.04
Change: +1.60 (2.18%)
Volume: 1.1 M
4:00PM ET 9/16/2021
 
 

Repligen Corp ( NASDAQ )

Price: $299.88
Change: +3.48 (1.17%)
Volume: 482.1 K
4:00PM ET 9/16/2021
 
 

Natera Inc ( NASDAQ )

Price: $120.43
Change: +0.19 (0.16%)
Volume: 334.7 K
3:59PM ET 9/16/2021
 
 

Intellia Therapeutics Inc ( NASDAQ )

Price: $153.57
Change: +3.13 (2.08%)
Volume: 719.2 K
3:59PM ET 9/16/2021
 

Read more news Recent News

Stifel Upgrades BioMarin Pharmaceutical to Buy from Hold, Adjusts Price Target to $96 from $86
7:37AM ET 9/09/2021 MT Newswires

BioMarin Pharmaceutical (BMRN) has an average rating of outperform and price targets ranging from $81 to $165, according to analysts polled by Capital IQ....

Sector Update: Health Care Stocks Falling This Afternoon
3:54PM ET 9/07/2021 MT Newswires

Health care stocks traded above their earlier lows this afternoon, with the NYSE Health Care Index falling 0.7% while the SPDR Health Care Select Sector...

Sector Update: Health Care
3:35PM ET 9/07/2021 MT Newswires

Health care stocks traded above their earlier lows this afternoon, with the NYSE Health Care Index falling 0.7% while the SPDR Health Care Select Sector...

Sector Update: Health Care Stocks Flat To Lower Pre-Bell Tuesday
9:15AM ET 9/07/2021 MT Newswires

Health care stocks were flat to lower pre-bell Tuesday. The iShares NASDAQ Biotechnology Index (IBB) was inactive while the Health Care SPDR (XLV) was down...

View all Commentary and Analysis

Ascendis Pharma: A Promising Platform And A Rich Valuation
9:38AM ET 9/10/2021 Seeking Alpha

BioMarin: The New Obstacle To Growth
4:40PM ET 9/09/2021 Seeking Alpha

Wall Street Breakfast: El Salvador Adopts Bitcoin (Podcast)
8:08AM ET 9/07/2021 Seeking Alpha

Wall Street Breakfast: Reddit Targets Bitcoin
6:36AM ET 9/07/2021 Seeking Alpha

Company Profile

Business DescriptionBioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA. View company web site for more details
Address770 Lindaro Street
San Rafael, California 94901
Phone+1.415.506.6700
Number of Employees2,849
Recent SEC Filing07/19/20214
Chairman & Chief Executive OfficerJean-Jacques Bienaimé
Chief Financial Officer & Executive Vice PresidentBrian R. Mueller
Chief Information OfficerEduardo E. Von Pervieux
President-Worldwide Research & DevelopmentHenry J. Fuchs

Company Highlights

Price Open$76.66
Previous Close$77.27
52 Week Range$71.65 - 92.57
Market Capitalization$14.0 B
Shares Outstanding183.4 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/04/2021

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings18.18
Earnings per Share$4.28
Beta vs. S&P 500N/A
Revenue$1.5 B
Net Profit Margin43.64%
Return on Equity20.22%

Analyst Ratings as of 09/08/2021

Buy
16
Overweight
2
Hold
4
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset